Skip to content
Curevo VaccineCurevo Vaccine
  • About
    • About Us
    • Management Team
  • Programs
    • Amezosvatein for Shingles
    • Amezosvatein for Chickenpox
  • Contact Us

Tag: investigational vaccine

George-Simeon 2048 x 1152
10 Feb, 2022
News, Vaccines

A small Seattle biotech wants to take on GlaxoSmithKline’s emerging Shingrix blockbuster. RA Capital is on board

by curevovaccine
Shingles Vaccine by Curevo 4480 x 6720
18 Mar, 2021
News, Press Releases, Vaccines

SAHPRA Approval Press Announcement 2021

by curevovaccine
Shingle and Varicella vaccines at Curevo 6000x4000
15 Sep, 2020
News, Vaccines

Curevo Vaccine Announces Robust Antibody Response Results of Phase I Clinical Trial of Investigational Vaccine for Shingles CRV-101

by curevovaccine

Recent Posts

  • Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention May 26, 2026
  • Curevo Enrolls First Participants in Phase 2 Extension Trial June 2, 2025
  • Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine March 17, 2025
  • Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine January 12, 2025

Categories

  • Events2
  • News8
  • Press Releases16
  • Vaccines8

Tags

  • adjuvanted vaccine
  • biotechnology company
  • clinical studies
  • CMO
  • CRV-101
  • Guy De La Rosa
  • infectious disease
  • investigational vaccine
  • JMP24
  • Scientific research
  • SHINGLES
  • Shingles Vaccine
  • Shingrix
  • subunit vaccines
  • VACCINE
  • varicella zoster virus
Curevo Vaccine logo white 158x90

___________________

A wholly owned subsidiary of Eli Lilly and Company

Curevo Inc.
18911 N Creek Pkwy #150
Bothell, WA 98011

+1.206.492.5722

Terms of Use
Privacy Policy
Cookie Policy

Consumer Health Privacy Notice

 © 2026 Curevo Inc.® All rights reserved.

Loading Comments...